Aptar Beauty creates refillable pump for L’Occitane hand care redesign
Aptar Beauty has provided L’Occitane en Provence with custom dispensing pumps that support the packaging redesign of the beauty brand’s hand care collection, transforming the products into refillable and reusable objects.
USDA Base Acre Review Deadline Closes, Setting Stage for 2026 Farm Program Enrollment
September 2026, Washington, D.C.: Landowners and producers had until August 31 to review and, if necessary, dispute new …
Novartis: Three deaths put CAR-T expansion into autoimmune diseases on hold
Why it matters: The promise of CAR-T therapy is no longer limited to cancer. After transforming treatment for several blood cancers, the technology is increasingly being explored as a potential way to reset the immune system in severe autoimmune diseases.
TraceIQ Launched to Maximize Pharmaceutical Traceability
Systech launched TraceIQ™, an intelligent, enterprise traceability platform designed to address the evolving operational aspects of pharmaceutical and biopharma supply chains.
FAO Warns of Worsening Soil Degradation as Global Adoption of Sustainable Practices Lags
September 2026, Rome: Soil degradation is worsening across many parts of the world, while proven practices to protect an…
Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy
Genprex selected Andelyn Biosciences to support scale-up manufacturing for its diabetes gene therapy program. Its product candidate is designed to deliver the Pdx1 and MafA genes directly to the pancreas via the pancreatic duct using an AAV vector. The program is being developed as a potential treatment for type 1 and type 2 diabetes.
Advanced Imaging Technique Reveals Immune Cell Metabolic States in Blood Samples
When a patient is facing certain cancers or an immune condition, clinicians turn to their white blood cells for clues about disease progression and treatment effects. Clinical labs isolate peripheral blood mononuclear cells (PBMCs)—which are predominantly immune cells—from a blood draw, and assess the abundance different cell types, along with some basic measures of how they’re functioning. PBMCs are in addition the starting point for CAR T cell therapies, which engineer a patient’s own immune cells to fight certain cancers.
Lilly Looks Beyond Obesity with Up-to-$2.9B Acquisition of Merida Biosciences
Eli Lilly’s biotech buying spree continues as the pharma giant is planning to carry out its 13th buyout of a biotech this year, agreeing to acquire Merida Biosciences, a developer of precision therapies for serious autoimmune and allergic diseases, for up to $2.875 billion, the companies said.
French Govt Invests €3.7M in Nūmi to Scale Up Cell-Cultured Breast Milk
French cellular agriculture player Nūmi has been selected in the French government’s i-Démo 5 R&D funding programme, netting €3.7M ($4.3M) in non-dilutive funding to scale up its cell-cultured breast milk.
Paleo Bags $2.3M to Advance Regulatory Filings for Animal-Free Meat Protein
Plant-based meat is still battling the inferior taste allegations, and addressing these could be the key to restoring the adoption levels that first brought them into the mainstream.